Belite Bio Common Stock

Belite Bio (BLTE) currently reports a common stock of $800M as of March 2026. That compares with $160M in the prior-year period — up 403.4% year over year. Use the charts on this page to explore Belite Bio's common stock history and peer comparisons.

Belite Bio's common stock increased from $160M to $800M — a 403.4% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Belite Bio reported $800M in common stock as of March 2026. That compares with $160M in the prior-year period — up 403.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current common stock of $800M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Belite Bio, and consider following BLTE for alerts when major investors trade the stock.